Evidence map›Paper›PMID 12634840›Full record

ReviewEMBO reports2003

The Ark1/Prk1 family of protein kinases. Regulators of endocytosis and the actin skeleton.

Elizabeth Smythe, Kathryn R Ayscough

Open access · greenAbstract readReview
In one paragraph

Review in EMBO reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Endocytosis and trans-Golgi Network in Yeast.Sub-cellular biochemistry · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. eLife · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Modularly engineeringFrontiers in bioengineering and biotechnology · 2023
    Article
  12. Article
  13. Kinase Inhibitors as Underexplored Antiviral Agents.Journal of medicinal chemistry · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K.ACS medicinal chemistry letters · 2020
    Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Elizabeth SmytheCentre for Developmental Genetics, Department of Biomedical Sciences, University of Sheffield, Sheffield S10 2TN, UK. e.smythe@sheffield.ac.uk
Kathryn R Ayscough
University of Glasgow · GBUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ark/Prk serine/threonine kinases initiate phosphorylation cycles that control the endocytic machinery in mammalian cells and in yeast, and the actin cytoskeleton in yeast. The members of this protein family are unified by homologies in their kinase domain, but are generally diverse in their other domains. The evolution of Ark/Prk family members in different organisms may have allowed the conserved role of the kinase domain, which is required for the phosphorylation of both endocytic and cytoskeletal components, to be coupled to other functional domains.

Indexed as

Saccharomyces cerevisiae ProteinsActinsAnimalsAurora KinasesEndocytosisMammalsPhosphorylationProtein Kinase CProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSignal TransductionActinsARK1 protein, S cerevisiaeAurora KinasesProtein Kinase Cprotein kinase NProtein Serine-Threonine KinasesSaccharomyces cerevisiae Proteins

Identifiers

PMID12634840
PMCPMC1315904
OpenAlexW2080959025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.